-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Enhabit (EHAB) Scheduled to Post Earnings on Tuesday
Enhabit (EHAB) Scheduled to Post Earnings on Tuesday
Enhabit (NYSE:EHAB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, February 14th. Analysts expect Enhabit to post earnings of $0.25 per share for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.
Enhabit Price Performance
Shares of NYSE:EHAB opened at $14.41 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The firm's 50-day moving average is $13.89 and its two-hundred day moving average is $14.22. Enhabit has a 1 year low of $11.65 and a 1 year high of $25.25.
Get Enhabit alerts:Insider Buying and Selling
In related news, Director Jeffrey Bolton purchased 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
Institutional Investors Weigh In On Enhabit
A number of hedge funds and other institutional investors have recently bought and sold shares of EHAB. Millennium Management LLC purchased a new position in shares of Enhabit in the second quarter valued at $230,000. Envestnet Asset Management Inc. purchased a new position in shares of Enhabit in the third quarter valued at $143,000. UBS Group AG increased its position in shares of Enhabit by 407,300.0% in the third quarter. UBS Group AG now owns 12,222 shares of the company's stock valued at $171,000 after buying an additional 12,219 shares in the last quarter. Macquarie Group Ltd. purchased a new position in shares of Enhabit in the third quarter valued at $187,000. Finally, Teachers Retirement System of The State of Kentucky purchased a new position in shares of Enhabit in the third quarter valued at $192,000. Institutional investors and hedge funds own 95.55% of the company's stock.Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on EHAB shares. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. UBS Group assumed coverage on shares of Enhabit in a research note on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target on the stock. Finally, Credit Suisse Group dropped their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.43.
About Enhabit
(Get Rating)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Recommended Stories
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
Enhabit (NYSE:EHAB – Get Rating) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, February 14th. Analysts expect Enhabit to post earnings of $0.25 per share for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.
EnHabit(纽约证券交易所代码：EHAB-GET Rating)计划在2月14日周二股市收盘后公布季度收益结果。分析师预计，EnHabit本季度每股收益为0.25美元。有兴趣参加公司收益电话会议的个人可以使用此链接进行。
Enhabit Price Performance
居住性价比
Shares of NYSE:EHAB opened at $14.41 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.63. The firm's 50-day moving average is $13.89 and its two-hundred day moving average is $14.22. Enhabit has a 1 year low of $11.65 and a 1 year high of $25.25.
纽约证券交易所：Ehab的股票周二开盘报14.41美元。该公司的流动比率为1.50，速动比率为1.50，债务权益比率为0.63。该公司的50日移动均线切入位在13.89美元，200日移动均线切入位在14.22美元。EnHabit的一年低点为11.65美元，一年高位为25.25美元。
Insider Buying and Selling
内幕买卖
In related news, Director Jeffrey Bolton purchased 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 9th. The stock was purchased at an average cost of $12.75 per share, with a total value of $25,500.00. Following the completion of the acquisition, the director now directly owns 14,597 shares in the company, valued at $186,111.75. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
在相关新闻中，董事的杰弗里·波顿在11月9日星期三的一笔交易中购买了2,000股该公司的股票。这只股票是以每股12.75美元的平均价格购买的，总价值为25,500.00美元。收购完成后，董事现在直接拥有该公司14,597股，价值186,111.75美元。此次收购是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过这个环节.
Institutional Investors Weigh In On Enhabit
机构投资者对EnHabit的看法
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
A number of analysts recently weighed in on EHAB shares. CJS Securities started coverage on shares of Enhabit in a research note on Tuesday, December 13th. They set a "market perform" rating and a $18.00 target price on the stock. Stifel Nicolaus assumed coverage on shares of Enhabit in a research note on Monday, December 5th. They issued a "buy" rating and a $17.00 price target on the stock. Oppenheimer assumed coverage on shares of Enhabit in a research note on Thursday, October 13th. They issued a "market perform" rating on the stock. UBS Group assumed coverage on shares of Enhabit in a research note on Thursday, December 8th. They issued a "sell" rating and a $12.00 price target on the stock. Finally, Credit Suisse Group dropped their price target on shares of Enhabit from $19.00 to $15.00 and set a "neutral" rating on the stock in a research note on Friday, November 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $16.43.
一些分析师最近加入了对Ehab股票的看法。CJS证券于12月13日(星期二)在一份研究报告中开始报道EnHabit的股票。他们为该股设定了“市场表现”评级和18.00美元的目标价。Stifel Nicolaus在12月5日星期一的一份研究报告中假设了对EnHabit股票的报道。他们对该股给予了“买入”评级和17.00美元的目标价。奥本海默在10月13日星期四的一份研究报告中对EnHabit的股票进行了报道。他们对该股给予了“市场表现”的评级。瑞银集团在12月8日星期四的一份研究报告中对EnHabit的股票进行了报道。他们对该股给予了“卖出”评级和12.00美元的目标价。最后，瑞士信贷集团在11月4日星期五的一份研究报告中将EnHabit的股票目标价从19.00美元下调至15.00美元，并将其股票评级定为“中性”。两名分析师对该股的评级为卖出，四名分析师给予持有评级，两名分析师给予该股买入评级。根据MarketBeat.com的数据，该股的共识评级为持有，共识目标价为16.43美元。
About Enhabit
关于居住
(Get Rating)
(获取评级)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
EnHabit，Inc.在美国提供家庭健康和临终关怀服务。它的家庭健康服务包括患者教育、疼痛管理、伤口护理和换药、心脏康复、输液治疗、药物管理和熟练的观察和评估服务；治疗慢性疾病和状况的做法，包括糖尿病、高血压、关节炎、阿尔茨海默病、低视力、椎管狭窄、帕金森病、骨质疏松症、复杂伤口护理和慢性疼痛，以及针对糖尿病、充血性心力衰竭、骨科术后手术或损伤和呼吸系统疾病的特定疾病计划；以及物理、职业和语言治疗师提供治疗服务。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Enhabit (EHAB)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
- 免费获取StockNews.com关于EnHabit的研究报告(Ehab)
- 劲量控股公司；失去电力或使购买时间带电？
- 康明斯能再创新高吗？
- 如何找到可以投资和交易的细价股
- ONSemi以优异的业绩走得更高
- 泰森食品第一季度对史泰博股票意味着什么
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
接受《居住者日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对EnHabit和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧